Antigenic properties and protective capacity of a cyclic peptide corresponding to site A of influenza virus haemagglutinin.

No abstract is available for this paper.

• Publication year

  1990

• Venue

  Vaccine

• Publication date

  1990-08-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/0264-410X(90)90086-2PMID 2396470
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Antibodies to synthetic peptides from the preS1 region of the hepatitis B virus (HBV) envelope (env) protein are virus-neutralizing and protective.

  1989cited by this paper
• Non-responsiveness to a foot-and-mouth disease virus peptide overcome by addition of foreign helper T-cell determinants

  1987cited by this paper
• Conformational‐dependent recognition of influenza virus hemagglutinin by murine T helper clones

  1986cited by this paper
• Immunogenicity of loop-structured short synthetic peptides mimicking the antigenic site A of influenza virus hemagglutinin.

  1986cited by this paper
• Antibodies to a synthetic peptide from the preS 120-145 region of the hepatitis B virus envelope are virus neutralizing.

  1986cited by this paper
• Protection of cattle against foot-and-mouth disease by a synthetic peptide.

  1986cited by this paper
• Induction of anti‐HIV neutralizing antibodies by synthetic peptides.

  1986cited by this paper
• Synthetic peptides from four separate regions of the poliovirus type 1 capsid protein VP1 induce neutralizing antibodies.

  1985cited by this paper
• Ubiquity of the repetitive epitope of the CS protein in different isolates of human malaria parasites.

  1985cited by this paper
• Specificity and cross-reactivity of synthetic peptides derived from a major antigenic site of influenza hemagglutinin.

  1985cited by this paper
• Antibodies elicited by influenza virus hemagglutinin fail to bind to synthetic peptides representing putative antigenic sites.

  1985cited by this paper
• Three-dimensional structure of an antigenic mutant of the influenza virus haemagglutinin

  1984cited by this paper
• Immunity and protection against influenza virus by synthetic peptide corresponding to antigenic sites of hemagglutinin.

  1984cited by this paper
• An antigenic map of the haemagglutinin of the influenza Hong Kong subtype (H3N2), constructed using mouse monoclonal antibodies.

  1984cited by this paper
• Antibodies against synthetic peptides of the B subunit of cholera toxin: crossreaction and neutralization of the toxin.

  1983cited by this paper
• Priming for and induction of anti-poliovirus neutralizing antibodies by synthetic peptides

  1983cited by this paper
• Anti-influenza response achieved by immunization with a synthetic conjugate.

  1982cited by this paper
• Protection against foot-and-mouth disease by immunization with a chemically synthesized peptide predicted from the viral nucleotide sequence

  1982cited by this paper
• Immunogenic structure of the influenza virus hemagglutinin.

  1982cited by this paper
• Antigenic activity of a synthetic peptide comprising the "loop" region of influenza virus hemagglutinin.

  1982cited by this paper
• Structural identification of the antibody-binding sites of Hong Kong influenza haemagglutinin and their involvement in antigenic variation

  1981cited by this paper
• Structure of the haemagglutinin membrane glycoprotein of influenza virus at 3 Å resolution

  1981cited by this paper
• The rapid determination of binding constants for antiviral antibodies by a radioimmunoassay. An analysis of the interaction between hybridoma proteins and influenza virus.

  1979cited by this paper
• Future influenza vaccines and the use of genetic recombinants.

  1969cited by this paper

• Prevalence of antibodies against a cyclic peptide mimicking the FG loop of the human papillomavirus type 16 capsid among Tunisian women

  2020cites this paper
• Generation of a Reassortant Influenza A Subtype H3N2 Virus Expressing Gaussia Luciferase

  2019cites this paper
• HIV/AIDS: Immunochemistry, Reductionism and Vaccine Design: A Review of 20 Years of Research

  2019cites this paper
• Peptide Antibodies in Clinical Laboratory Diagnostics.

  2017cites this paper
• Predicting peptide vaccine candidates against H1N1 influenza virus through theoretical approaches

  2015cites this paper
• Evaluating the Immunogenic Potential of Synthetic Influenza T-B & B-T Peptides

  2012cites this paper
• Characterization of a branched lipopeptide candidate vaccine against influenza A/Puerto Rico 8/34 which is recognized by human B and T-cell immune responses

  2011cites this paper
• Animal Models for Influenza Virus Pathogenesis and Transmission

  2010cites this paper
• Solid-phase synthesis and on-resin cyclization of a disulfide bond peptide and lactam analogues corresponding to the major antigenic site of HIV gp41 protein.

  2009cites this paper
• Simultaneous multiple synthesis and selective conjugation of cyclized peptides derived from a surface loop of a meningococcal class 1 outer membrane protein.

  2009cites this paper
• Antibody recognition and conformational flexibility of a plaque-specific beta-amyloid epitope modulated by non-native peptide flanking regions.

  2008cites this paper
• Synthetic peptide AT20 coupled to KLH elicits antibodies against a conserved conformational epitope from a major functional area of the HIV-1 matrix protein p17.

  2008cites this paper
• Importance of spliceosomal RNP1 motif for intermolecular T-B cell spreading and tolerance restoration in lupus

  2007influential citation
• Antigenic analysis of bean pod mottle virus using linear and cyclized synthetic peptides

  2005cites this paper
• A Prototype Prophylactic Anti-Influenza Preparation in Aerosol Form on the Basis of Abies sibirica Polyprenols

  2005cites this paper
• Preclinical studies on immunogenicity of the HIV‐1 p17‐based synthetic peptide AT20‐KLH

  2004cites this paper
• Immunogenicity of peptide-vaccine candidates predicted by molecular dynamics simulations.

  2003cites this paper
• Synthetic peptide-based highly immunogenic liposomal constructs.

  2003cites this paper
• Structural and immunological characterisation of heteroclitic peptide analogues corresponding to the 600-612 region of the HIV envelope gp41 glycoprotein.

  2002cites this paper
• Mimotopes of viral antigens and biologically important molecules as candidate vaccines and potential immunotherapeutics.

  2002cites this paper
• Recognition of peptides by antibodies and investigations of affinity using biosensor technology.

  2001cites this paper
• A Defined Conformational Epitope from the C4 Domain of HIV Type 1 Glycoprotein 120: Anti-Cyclic C4 Antibodies from HIV-Positive Donors Magnify Glycoprotein 120 Suppression of Interleukin 2 Produced by T Cells

  2001cites this paper
• The development of a mimotope-based synthetic peptide vaccine against respiratory syncytial virus.

  2001cites this paper
• Antigenicity modulation upon peptide cyclization: application to the GH loop of foot-and-mouth disease virus strain C1-Barcelona.

  2001cites this paper
• The bare skin and the nose as non-invasive routes for administering peptide vaccines.

  2001cites this paper
• The Recognition of Proteins and Peptides by Antibodies

  2000cites this paper
• The recognition of proteins and peptides by antibodies.

  2000cites this paper
• Affinity and potency of proinhibitory antipeptide antibodies against CYP2D6 is enhanced using cyclic peptides as immunogens.

  2000cites this paper
• A structure-based approach to a synthetic vaccine for HIV-1.

  2000cites this paper
• Native‐like cyclic peptide models of a viral antigenic site: finding a balance between rigidity and flexibility

  2000cites this paper
• Conformation-dependent antibody response to Pseudomonas aeruginosa outer membrane proteins induced by immunization in humans.

  2000cites this paper
• Peptide mimotopes as candidate vaccines.

  2000cites this paper
• Chapter 8 – Synthetic peptides as vaccines

  1999cites this paper
• Chapter 3 – Immunization with peptides

  1999cites this paper
• Chapter 1 - Molecular dissection of protein antigens and the prediction of epitopes

  1999cites this paper
• Molecular design versus empirical discovery in peptide-based vaccines. Coming to terms with fuzzy recognition sites and ill-defined structure-function relationships in immunology.

  1999cites this paper
• Molecular design versus empirical discovery in peptide-based vaccines. Coming to terms with fuzzy recognition sites and ill-defined structure-function relationships in immunology.

  1999cites this paper
• A cyclic peptide analogue of the loop III region of platelet-derived growth factor-BB is a synthetic antigen for the native protein.

  1999cites this paper
• A comparative study of cyclization strategies applied to the synthesis of head-to-tail cyclic analogs of a viral epitope.

  1999cites this paper
• Liposomes: from membrane models to gene therapy

  1998cites this paper
• Linear and cyclic peptides mimicking the disulfide loops in HIV-2 envelope glycoprotein induced antibodies with different specificity.

  1997cites this paper
• A cyclic disulfide peptide reproduces in solution the main structural features of a native antigenic site of foot-and-mouth disease virus.

  1997cites this paper
• Production of Virus-Specific Antisera Using Synthetic Peptides Corresponding to Sequences in the Yellow Fever E Protein: Brief Report

  1997cites this paper
• Conformational display of two neutralizing epitopes of HIV-1 gp41 on the Flock House virus capsid protein.

  1996cites this paper
• Protection of mice against lethal viral infection by synthetic peptides corresponding to B- and T-cell recognition sites of influenza A hemagglutinin.

  1995cites this paper
• Recombinant antibodies containing an engineered B-cell epitope capable of eliciting conformation-specific antibody responses.

  1995cites this paper
• Cellular immunity in relation to pertussis vaccination and infection.

  1995cites this paper
• Conjugates of synthetic cyclic peptides elicit bactericidal antibodies against a conformational epitope on a class 1 outer membrane protein of Neisseria meningitidis

  1995cites this paper
• Immunogenicity of T epitope-containing cyclic peptides. Increasing neutralizing antibody responses by introducing fine chemical changes.

  1995cites this paper
• Conformational mimicry of a chlamydial neutralization epitope on filamentous phage.

  1994cites this paper
• Strategies for mapping and imitating viral B-cell epitopes

  1994cites this paper
• Synthetic Peptides and Purified Antigens as Vaccines

  1994cites this paper
• Ability of linear and cyclic peptides of neutralization antigenic site 1 of poliovirus type 1 to induce virus cross-reactive and neutralizing antibodies.

  1994cites this paper
• Selective induction of protection against influenza virus infection in mice by a lipid-peptide conjugate delivered in liposomes.

  1994cites this paper
• Structural and dynamic studies of two antigenic loops from haemagglutinin: A relaxation matrix approach

  1993cites this paper
• Evaluation of structure-antigenicity relationship of peptides from human immunodeficiency virus type 1 (HIV-1) p18 protein by circular dichroism.

  1993cites this paper
• Synthetic peptide vaccines.

  1993cites this paper
• Induction of immune response against a short synthetic peptide antigen coupled to small neutral liposomes containing monophosphoryl lipid A.

  1993cites this paper
• Cyclic disulfide model of the major antigenic site of serotype‐C foot‐and‐mouth disease virus

  1993cites this paper
• Lyophilized liposomes as shelf items for the preparation of immunogenic liposome-peptide conjugates.

  1993cites this paper
• Synthetic peptides versus natural antigens in immunoassays.

  1993cites this paper
• Factors governing the binding and recognition of foreign and self-peptides by MHC class II.

  1993cites this paper
• Correlation between the location of antigenic sites and the prediction of turns in proteins.

  1993cites this paper
• Peptides reactive with a transmission-blocking monoclonal antibody against Plasmodium falciparum Pfs25: 2000-fold affinity increase by PEPSCAN-based amino acid substitutions.

  1992cites this paper
• Understanding antigen-antibody interactions. Implications in reagent design

  1992cites this paper
• The conformational specificity of viral epitopes.

  1992cites this paper
• How can peptide vaccines work?

  1992cites this paper
• Structural basis of antigenic specificity and design of new vaccines

  1992cites this paper
• Specificity of anti-P25 antibodies produced against whole HIV-1 particles or soluble forms of the protein.

  1992cites this paper
• Computing the geometry of a molecule in dihedral angle space using n.m.r.-derived constraints. A new algorithm based on optimal filtering.

  1992cites this paper
• Protein antigenicity.

  1992cites this paper
• Immunogenicity of free synthetic peptides corresponding to T helper epitopes of the influenza HA 1 subunit

  1992cites this paper
• Design and immunological properties of topographic immunogenic determinants of a protein antigen (LDH-C4) as vaccines.

  1992cites this paper
• The conformational specificity of viral epitopes.

  1992cites this paper
• Modelling the dynamics of an antigenic peptide using NMR relaxation data.

  1992cites this paper
• Foreign epitopes in immunodominant regions of hepatitis B core particles are highly immunogenic and conformationally restricted.

  1991cites this paper
• Parameters affecting the immunogenicity of a liposome‐associated synthetic hexapeptide antigen

  1991cites this paper
• Structure of viral B-cell epitopes.

  1990cites this paper
• Author index

  1990cites this paper
• Structure of viral B-cell epitopes.

  1990cites this paper